Enhanced  	Enhanced  	 NNP	O
Retinal  	Retinal  	 NNP	B-NP
Ganglion  	Ganglion  	 NNP	I-NP
Cell  	Cell  	 NNP	I-NP
Survival  	Survival  	 NNP	I-NP
in  	in  	 IN	O
Glaucoma  	Glaucoma  	 NNP	O
by  	by  	 IN	O
Hypoxic  	Hypoxic  	 NNP	B-NP
Postconditioning  	Postconditioning  	 NNP	I-NP
After  	After  	 IN	O
Disease  	Disease  	 NNP	B-NP
Onset  	Onset  	 NNP	I-NP
The  	The  	 DT	O
neuroprotective  	neuroprotective  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	I-NP
adaptive  	adaptive  	 JJ	I-NP
epigenetics 	epigenetics 	 NN	I-NP
,  	,  	 ,	O
wherein  	wherein  	 JJ	O
beneficial  	beneficial  	 JJ	O
gene  	gene  	 NN	B-NP
expression  	expression  	 NN	I-NP
changes  	changes  	 NNS	I-NP
are  	are  	 VBP	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
nonharmful  	nonharmful  	 JJ	B-NP
conditioning  	conditioning  	 NN	I-NP
stimuli 	stimuli 	 NNS	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
now  	now  	 RB	O
well  	well  	 RB	O
established  	established  	 VBN	O
in  	in  	 IN	O
several  	several  	 JJ	O
acute 	acute 	 NN	O
,  	,  	 ,	O
preclinical  	preclinical  	 JJ	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	B-NP
injury  	injury  	 NN	I-NP
models 	models 	 NNS	I-NP
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
a  	a  	 DT	O
mouse  	mouse  	 NN	O
model  	model  	 NN	O
of  	of  	 IN	O
glaucoma 	glaucoma 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
demonstrated  	demonstrated  	 VBD	O
retinal  	retinal  	 JJ	B-NP
ganglion  	ganglion  	 JJ	I-NP
cell  	cell  	 NN	I-NP
( 	( 	 -LRB-	O
RGC 	RGC 	 NNP	B-NP
)  	)  	 -RRB-	O
protection  	protection  	 NN	O
by  	by  	 IN	O
repetitively  	repetitively  	 JJ	O
preconditioning  	preconditioning  	 NN	B-NP
with  	with  	 IN	O
hypoxia  	hypoxia  	 JJ	B-NP
prior  	prior  	 JJ	I-NP
to  	to  	 TO	O
disease  	disease  	 NN	B-NP
onset 	onset 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
an  	an  	 DT	O
epigenetic  	epigenetic  	 JJ	B-NP
approach  	approach  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
yield  	yield  	 VB	O
benefits  	benefits  	 NNS	O
in  	in  	 IN	O
chronic  	chronic  	 JJ	B-NP
neurodegenerative  	neurodegenerative  	 JJ	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Herein 	Herein 	 NNP	O
,  	,  	 ,	O
we  	we  	 PRP	O
determined  	determined  	 VBD	O
whether  	whether  	 IN	O
presenting  	presenting  	 VBG	O
the  	the  	 DT	O
repetitive  	repetitive  	 JJ	B-NP
hypoxic  	hypoxic  	 JJ	I-NP
stimulus  	stimulus  	 NN	I-NP
after  	after  	 IN	O
disease  	disease  	 NN	B-NP
initiation  	initiation  	 NNS	I-NP
[ 	[ 	 -LRB-	O
repetitive  	repetitive  	 FW	B-NP
hypoxic  	hypoxic  	 FW	I-NP
postconditioning  	postconditioning  	 FW	I-NP
( 	( 	 -LRB-	O
RH-Post 	RH-Post 	 NNP	B-NP
) 	) 	 -RRB-	O
]  	]  	 -RRB-	O
could  	could  	 MD	O
afford  	afford  	 VB	O
similar  	similar  	 JJ	O
functional  	functional  	 NN	O
and  	and  	 CC	O
morphologic  	morphologic  	 JJ	B-NP
protection  	protection  	 NN	I-NP
against  	against  	 IN	O
glaucomatous  	glaucomatous  	 JJ	B-NP
RGC  	RGC  	 NNP	I-NP
injury 	injury 	 NN	I-NP
.  	.  	 .	O
Chronic  	Chronic  	 JJ	B-NP
elevations  	elevations  	 NNS	I-NP
in  	in  	 IN	O
intraocular  	intraocular  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
IOP 	IOP 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
induced  	induced  	 VBN	O
unilaterally  	unilaterally  	 RB	O
in  	in  	 IN	O
adult  	adult  	 JJ	O
male  	male  	 JJ	O
C57BL 	C57BL 	 CD	O
/ 	/ 	 CD	O
6  	6  	 CD	O
mice  	mice  	 NNS	O
by  	by  	 IN	O
episcleral  	episcleral  	 JJ	B-NP
vein  	vein  	 NN	I-NP
ligation 	ligation 	 NN	I-NP
.  	.  	 .	O
Mice  	Mice  	 NNS	O
were  	were  	 VBD	O
randomized  	randomized  	 VBN	O
to  	to  	 TO	O
an  	an  	 DT	O
RH-Post  	RH-Post  	 JJ	B-NP
[ 	[ 	 -LRB-	O
1  	1  	 CD	O
h  	h  	 NN	O
of  	of  	 IN	O
systemic  	systemic  	 JJ	B-NP
hypoxia  	hypoxia  	 NNS	I-NP
( 	( 	 -LRB-	O
11 	11 	 CD	O
%  	%  	 NN	O
oxygen 	oxygen 	 NN	B-NP
)  	)  	 -RRB-	O
every  	every  	 DT	O
other  	other  	 JJ	O
day 	day 	 NN	O
,  	,  	 ,	O
starting  	starting  	 VBG	O
4  	4  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
IOP  	IOP  	 NNP	B-NP
elevation 	elevation 	 CD	I-NP
]  	]  	 -RRB-	O
or  	or  	 CC	O
an  	an  	 DT	O
untreated  	untreated  	 JJ	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
After  	After  	 IN	O
3  	3  	 CD	O
weeks  	weeks  	 NNS	O
of  	of  	 IN	O
experimental  	experimental  	 JJ	B-NP
glaucoma 	glaucoma 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
21-27 	21-27 	 JJ	O
%  	%  	 NN	O
reduction  	reduction  	 NN	O
and  	and  	 CC	O
5-25 	5-25 	 CD	O
%  	%  	 NN	O
prolongation  	prolongation  	 NN	B-NP
in  	in  	 IN	O
flash  	flash  	 JJ	O
visual-evoked  	visual-evoked  	 JJ	O
potential  	potential  	 JJ	B-NP
amplitudes  	amplitudes  	 NN	I-NP
and  	and  	 CC	O
latencies 	latencies 	 NN	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
30 	30 	 CD	O
%  	%  	 NN	O
impairment  	impairment  	 NN	O
in  	in  	 IN	O
visual  	visual  	 JJ	O
acuity  	acuity  	 NN	B-NP
were  	were  	 VBD	O
robustly  	robustly  	 RB	O
improved  	improved  	 VBN	O
in  	in  	 IN	O
RH-Post-treated  	RH-Post-treated  	 JJ	B-NP
mice 	mice 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
was  	was  	 VBD	O
the  	the  	 DT	O
17 	17 	 CD	O
%  	%  	 NN	O
loss  	loss  	 NN	O
in  	in  	 IN	O
RGC  	RGC  	 NNP	B-NP
soma  	soma  	 JJ	I-NP
number  	number  	 NN	O
and  	and  	 CC	O
20 	20 	 CD	O
%  	%  	 NN	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
axon  	axon  	 JJ	B-NP
integrity 	integrity 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
protective  	protective  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
without  	without  	 IN	O
RH-Post  	RH-Post  	 JJ	B-NP
affecting  	affecting  	 VBG	I-NP
IOP 	IOP 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
findings  	findings  	 NNS	O
demonstrate  	demonstrate  	 VBP	O
that  	that  	 DT	O
functional  	functional  	 NN	O
and  	and  	 CC	O
morphologic  	morphologic  	 JJ	B-NP
protection  	protection  	 NN	I-NP
of  	of  	 IN	I-NP
RGCs  	RGCs  	 NNP	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
realized  	realized  	 VBN	O
by  	by  	 IN	O
stimulating  	stimulating  	 VBG	O
epigenetic  	epigenetic  	 JJ	B-NP
responses  	responses  	 NNS	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
early  	early  	 JJ	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
disease 	disease 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
thus  	thus  	 RB	O
constitute  	constitute  	 VB	O
a  	a  	 DT	O
new  	new  	 JJ	O
conceptual  	conceptual  	 JJ	B-NP
approach  	approach  	 NN	I-NP
to  	to  	 TO	O
glaucoma  	glaucoma  	 VB	O
therapeutics 	therapeutics 	 NNS	O
.  	.  	 .	O
